Piperoxan hydrochloride
≥99%
- Product Code: 102054
CAS:
135-87-5
| Molecular Weight: | 269.77 g./mol | Molecular Formula: | C₁₄H₂₀ClNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Piperoxan hydrochloride is primarily used in pharmacological research as an alpha-adrenergic blocking agent. It is often employed in studies to investigate the effects of adrenergic receptors on various physiological processes. By blocking these receptors, it helps researchers understand the role of adrenaline and noradrenaline in the body, particularly in the cardiovascular and nervous systems. Additionally, it has been utilized in experimental settings to study the mechanisms of hypertension and to explore potential treatments for conditions related to adrenergic overactivity. Its application in these areas contributes to the development of new therapeutic strategies targeting adrenergic pathways.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | €203.01 |
+
-
|
| 0.005 | 10-20 days | €406.02 |
+
-
|
Piperoxan hydrochloride
Piperoxan hydrochloride is primarily used in pharmacological research as an alpha-adrenergic blocking agent. It is often employed in studies to investigate the effects of adrenergic receptors on various physiological processes. By blocking these receptors, it helps researchers understand the role of adrenaline and noradrenaline in the body, particularly in the cardiovascular and nervous systems. Additionally, it has been utilized in experimental settings to study the mechanisms of hypertension and to explore potential treatments for conditions related to adrenergic overactivity. Its application in these areas contributes to the development of new therapeutic strategies targeting adrenergic pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :